067080

19,000 KRW
170
0.90%
Last update Dec 17, 3:00 PM KST
Post-market
Day range
18,550
19,120
Previous close
18,830
Open
18,900
Access this stock data via API
Subscribe
Daehwa Pharm Co. Ltd.
19,000.00
170
0.90%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 149.4B 141.4B 131.9B 117.2B
Cost of revenue 96.2B 96.0B 85.8B 73.5B
Gross profit 53.2B 45.4B 46.1B 43.7B
Operating expense
Research & development 7.2B 6.0B 5.4B 6.6B
Selling general and admin 24.6B 18.8B 16.2B 15.2B
Other operating expenses 1.2B 1.5B 829.7M 739.9M
Operating income 6.7B 2.0B 5.8B 3.3B
Non operating interest income
Income 23.6M 313.8M 314.2M 405.2M
Expense 5.5B 4.7B 2.4B 1.5B
Other income expense
Pretax income 1.5B -456.0M 2.4B 4.5B
Tax provision 683.3M 58.3M 1.2B 2.6B
Net income 829.8M -514.3M 1.2B 2.0B
Basic EPS 30 -65 64 127
Diluted EPS 30 -65 64 127
Basic average shares 17.5M 17.6M 17.4M 17.5M
Diluted average shares 17.5M 17.6M 17.4M 17.5M
EBITDA 14.1B 9.9B 13.0B 9.4B
Net income from continuing op. 829.8M -514.3M 1.2B 2.0B
Minority interests -298.4M -632.5M -105.5M 255.0M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 15 minutes

17:45
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:30 - 09:00
Main market
09:00 - 15:30
Post-market
15:30 - 18:00
All times are displayed in the Asia/Seoul timezone (KST, UTC+09:00).